SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-09-000435
Filing Date
2009-01-28
Accepted
2009-01-28 07:33:51
Documents
13
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2190064z20-f.htm 20-F 5016525
2 EXHIBIT 1.1 a2190064zex-1_1.htm EX-1.1 201173
3 EXHIBIT 1.2 a2190064zex-1_2.htm EX-1.2 479913
4 EXHIBIT 4.5 a2190064zex-4_5.htm EX-4.5 708694
5 EXHIBIT 4.6 a2190064zex-4_6.htm EX-4.6 171177
6 EXHIBIT 12.1 a2190064zex-12_1.htm EX-12.1 13711
7 EXHIBIT 12.2 a2190064zex-12_2.htm EX-12.2 13755
8 EXHIBIT 13.1 a2190064zex-13_1.htm EX-13.1 8947
9 EX-14.1 a2190064zex-14_1.htm EX-14.1 4873
10 G34282KA01I001.JPG g34282ka01i001.jpg GRAPHIC 2093
11 G34282KA03I001.JPG g34282ka03i001.jpg GRAPHIC 2093
12 G34282KC01I001.JPG g34282kc01i001.jpg GRAPHIC 2179
13 G34282KC05I001.JPG g34282kc05i001.jpg GRAPHIC 2179
  Complete submission text file 0001047469-09-000435.txt   6632520
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 09549717
SIC: 2834 Pharmaceutical Preparations